ZT

Zygimante Tarnauskaite

Research Scientist at Adrestia Therapeutics

Zygimante Tarnauskaite's work experience includes positions at various institutions, starting with their most recent role as a Research Scientist at Adrestia Therapeutics since September 2019. Prior to that, they served as a PhD Student at the MRC Institute of Genetics and Molecular Medicine, The University of Edinburgh, from September 2014 to November 2018. Zygimante also gained experience as a Summer Research Intern at the Okinawa Institute of Science and Technology in July to September 2014, an Honours Student at the Centre for Integrative Physiology from January to April 2014, and a Summer Student at the Wellcome Trust Centre for Cell Biology in July to August 2013. Zygimante had earlier roles as a Summer Student at the MRC Institute of Genetics and Molecular Medicine from May to July 2013, and as a Summer Intern at Karolinska Institutet from June to August 2012.

Zygimante Tarnauskaite completed their education in a chronological manner. Zygimante started their academic journey in 2010 at The University of Edinburgh, where they pursued a Bachelor of Science (BSc) degree in Biological Sciences with Honours in Molecular Biology. Zygimante successfully completed their undergraduate studies in 2014.

Following their bachelor's degree, Zygimante Tarnauskaite continued their education at The University of Edinburgh and commenced their Doctor of Philosophy (PhD) in Human Genetics, Genomics, and Disease in 2014. Zygimante dedicated herself to this research-intensive program for four years and successfully finished their PhD in 2018.

Based on the provided information, Zygimante Tarnauskaite's education history demonstrates their commitment to the field of genetics and genomics, starting with their undergraduate studies and culminating in the completion of their doctoral degree.

Location

Cambridge, United Kingdom

Links

Previous companies


Org chart

No direct reports

Teams


Offices


Adrestia Therapeutics

Adrestia Therapeutics are leaders in synthetic rescue, an approach that decodes the complexity of genetic networks to reveal new ways to treat diseases.


Industries

Employees

11-50

Links